Encouraging Cancer Research Through Deliberate Mutations

Darwinists are fond of mutations, because they think that they are the main mechanism by which slime-to-sandblaster evolution occurred. They have a problem finding undisputed beneficial mutations, which are highly unlikely in their worldview of random, purposeless events. But there are beneficial, targeted mutations by design.

"Digital Illustration Of Dna Structure" image credit: FreeDigitalPhotos.net / hywards

We have a passel of cancer cells every day, but our immune system fights them off. Our system even sends special mutations of its own making to trouble zones, as it was created to do. When the system fails and cancer cells grow out of control, that's when the problems set in. New research involves taking out cells, doing intelligently designed mutations, inserting them back — and having a huge success rate of leukemia patients going into remission. And no, evolutionary "science" had nothing to do with this.

CBS News has reported on a new cancer treatment tried on 35 terminally-ill, advanced-stage leukemia sufferers. The disease went into remission in 94%, or 33 of 35 patients! Dr. Michael Grossbard, New York University's Perlmutter Cancer Center leukemia specialist told CBS News, "Oncologists are reluctant to use the word extraordinary. But these [results] are extraordinary. These are really remarkable findings..." Real Science Radio host Bob Enyart turns to RSR's targeted-antibody expert, Jonathan Bartlett, who explains both the molecular biology behind this new treatment and the worldview implications ahead of it. Bartlett also discusses the impossibility that an evolutionist faces in trying to understand such a treatment and why so many scholars are fleeing Darwinism.

To listen to the discussion (free to listen online or download), click on "RSR Explains Extraordinary Cancer Antibody Treatment".